Buccal Drug Delivery System Growth Forecast 2025-2034: Trends, Opportunities, and Key Insights You Need to Know
Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!
What is the Predicted CAGR for the Buccal Drug Delivery System Market Over the Forecast Period of 2025 to 2034?
The buccal drug delivery system market size has grown rapidly in recent years. It will grow from $3.55 billion in 2024 to $3.91 billion in 2025 at a compound annual growth rate (CAGR) of 10.3%. The growth in the historic period can be attributed to early drug delivery innovations, pharmaceutical industry adoption, clinical studies and efficacy, market penetration strategies, disease-specific applications.
The buccal drug delivery system market size is expected to see rapid growth in the next few years. It will grow to $5.97 billion in 2029 at a compound annual growth rate (CAGR) of 11.1%. The growth in the forecast period can be attributed to patient-centric drug delivery, rising geriatric population, demand for targeted therapies, biologics and peptides delivery, regulatory support and approvals, investments in r&d. Major trends in the forecast period include patient convenience and compliance, advancements in drug formulations, rise in chronic diseases, pediatric and geriatric care, enhanced bioavailability.
How Are the key drivers Contributing to the Expansion of the buccal drug delivery system Market?
The rising prevalence of chronic diseases is expected to propel the growth of the buccal drug delivery systems market going forward. Chronic diseases refer to ailments that persist for a year or longer, such as cancer, heart disease, stroke, diabetes, cancer, and arthritis. These are the most prevalent chronic illnesses that can be managed but not cured and necessitate continuous nutrition and medical care. Buccal drug delivery systems provide appropriate and effective drug delivery for administering mucosal and transmucosal drugs that are required by several patients suffering from chronic diseases such as diabetes and cancer. For instance, in September 2023, according to the World Health Organization, a Switzerland-based specialized agency of the United Nations, there were 41 million deaths, which is 74% of those caused by non-communicable diseases (NCDs) or chronic diseases every year globally. There were 17.9 million deaths from cardiovascular diseases, 9.3 million deaths from cancer, 4.1 million deaths from chronic respiratory diseases, and 2.0 million deaths from diabetes. Therefore, the rising prevalence of chronic diseases drives the growth of the buccal drug delivery systems market.
Get Your Free Sample of the Global Buccal Drug Delivery System Market Report Now!
https://www.thebusinessresearchcompany.com/sample.aspx?id=8290&type=smp
Who Are the Top Companies Driving Innovation and Growth in the Buccal Drug Delivery System Market?
Major companies operating in the buccal drug delivery system market are:
• Teva Pharmaceuticals Industries Ltd._x000D_
• Pfizer Incorporated_x000D_
• GlaxoSmithKline Public Limited Company_x000D_
• Indivior PLC_x000D_
• Generex Biotechnology Corporation_x000D_
What Key Trends Are Currently Impacting the Buccal Drug Delivery System Market’s Development?
Major companies operating in the buccal drug delivery systems market are focusing on developing innovative solutions, such as oral treatment for plaque psoriasis, to improve patient outcomes and enhance the efficacy of drug delivery. Oral treatment for plaque psoriasis refers to the administration of medications taken by mouth to manage and alleviate the symptoms of plaque psoriasis, a chronic autoimmune condition characterized by the rapid growth of skin cells leading to thick, red, scaly patches. For instance, in September 2022, Bristol Myers Squibb, a US-based pharmaceutical industry company, received FDA approval for Sotyktu (deucravacitinib), an oral treatment for adults with moderate-to-severe plaque psoriasis. This approval marks the first new oral therapy for this condition in nearly a decade, offering a novel mechanism of action as a selective inhibitor of tyrosine kinase 2 (TYK2).
Get Instant Access to the Global Buccal Drug Delivery System Market Report with Swift Delivery!
https://www.thebusinessresearchcompany.com/report/buccal-drug-delivery-system-global-market-report
Which Primary Segments of the Buccal Drug Delivery System Market Are Driving Growth and Industry Transformations?
The buccal drug delivery system market covered in this report is segmented –
1) By Type: Sublingual, Buccal Tablets And Lozenges, Oral Sprays
2) By Application: Pain Management, Smoking Cessation, Angina Pectoris
3) By End-User: Hospitals, Ambulatory Centers, Other End-Users
Subsegments:
1) By Sublingual: Sublingual Tablets, Sublingual Films
2) By Buccal Tablets And Lozenges: Buccal Tablets, Buccal Lozenges
3) By Oral Sprays: Spray Solutions, Spray Gels
Which Geographical Regions Are Pioneering Growth in the Buccal Drug Delivery System Market?
North America was the largest region in the buccal drug delivery systems market share in 2024. The regions covered in the buccal drug delivery system market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
What Are the Key Characteristics That Define the Buccal Drug Delivery System Market?
The buccal drug delivery system refers to the injection of the desired medicine through the buccal mucosal membrane lining of the mouth cavity. This method is effective for administering mucosal and transmucosal drugs. Mucosal drug delivery aims for site-specific drug release on the mucosa, whereas transmucosal permeation entails drug absorption across the mucosal barrier and into the systemic circulation.
Browse Through More Similar Reports By The Business Research Company:
Implantable Drug Delivery Devices Global Market Report 2024
Injectable Drug Delivery Devices Global Market Report 2024
Drug Delivery Devices Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/drug-delivery-devices-global-market-report
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at [email protected]
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Found this article helpful? Share it on:
